| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Jiguang Qu CEO | HKEX Exchange | - ISIN |
| Hong Kong Country | 5,700 Employees | - Last Dividend | 24 Sep 2012 Last Split | - IPO Date |
SSY Group Limited operates as an investment holding company with a primary focus on the pharmaceutical sector. The organization is dedicated to the research, development, manufacturing, and distribution of a wide range of pharmaceutical products to hospitals and distributors both within the People's Republic of China and on an international level. The brand identity is represented under the "Shimen" brand name, emphasizing its commitment to quality and innovation in the healthcare industry. Originally established as Lijun International Pharmaceutical (Holding) Co., Ltd., it underwent a rebranding to SSY Group Limited in May 2015. Founded in 2004 and based in Wanchai, Hong Kong, SSY Group Limited serves as a subsidiary of China Pharmaceutical Co., Ltd., highlighting its significant role in the larger pharmaceutical domain.
SSY Group Limited offers an extensive portfolio of pharmaceutical products and services catered to meet the diverse needs of its clientele. These include: